Close

Analyst Ratings for Arbutus Biopharma (ABUS) [Neutrals]

ABUS Rating Summary

ABUS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ABUS
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $4.00 (+45.5%) * Over Last 12-Mos
Rating Score: 7.8 / 10   Percentile Rank: 82%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/24/2020 Baird Madhu Kumar Downgrade Neutral
(Outperform)
4.00
(N/A)
2.82
(2.75)
-2.48% Details
8/5/2016 Leerink Partners
» Updated 11/7/2017
N/A Downgrade Market Perform
(Outperform)
5.50
(4.00)
4.37
(2.75)
-37.07% Details